These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19884495)

  • 21. Endothelial Cell-Targeted Deletion of PPAR
    Akiyama TE; Skelhorne-Gross GE; Lightbody ED; Rubino RE; Shi JY; McNamara LA; Sharma N; Zycband EI; Gonzalez FJ; Liu H; Woods JW; Chang CH; Berger JP; Nicol CJB
    J Pharmacol Exp Ther; 2019 Mar; 368(3):514-523. PubMed ID: 30606762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective peroxisomal proliferators activated receptor gamma activity due to dominant-negative mutation synergizes with hypertension to accelerate cardiac fibrosis in mice.
    Kis A; Murdoch C; Zhang M; Siva A; Rodriguez-Cuenca S; Carobbio S; Lukasik A; Blount M; O'Rahilly S; Gray SL; Shah AM; Vidal-Puig A
    Eur J Heart Fail; 2009 Jun; 11(6):533-41. PubMed ID: 19395708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.
    Gayet C; Leray V; Saito M; Siliart B; Nguyen P
    Br J Nutr; 2007 Sep; 98(3):497-503. PubMed ID: 17475082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Energy balance and food intake: the role of PPARgamma gene polymorphisms.
    Cecil JE; Watt P; Palmer CN; Hetherington M
    Physiol Behav; 2006 Jun; 88(3):227-33. PubMed ID: 16777151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression.
    Chang CS; Yu SS; Ho LC; Chao SH; Chou TY; Shao AN; Kao LZ; Chang CY; Chen YH; Wu MS; Tsai PJ; Maeda N; Tsai YS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
    Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased PPAR gamma expression compromises perigonadal-specific fat deposition and insulin sensitivity.
    Tsai YS; Tsai PJ; Jiang MJ; Chou TY; Pendse A; Kim HS; Maeda N
    Mol Endocrinol; 2009 Nov; 23(11):1787-98. PubMed ID: 19749155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.
    Guignabert C; Alvira CM; Alastalo TP; Sawada H; Hansmann G; Zhao M; Wang L; El-Bizri N; Rabinovitch M
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1082-90. PubMed ID: 19801450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.
    Kleinhenz JM; Kleinhenz DJ; You S; Ritzenthaler JD; Hansen JM; Archer DR; Sutliff RL; Hart CM
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1647-54. PubMed ID: 19666848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fat Mass Reduction With Adipocyte Hypertrophy and Insulin Resistance in Heterozygous PPARγ Mutant Rats.
    Gumbilai V; Ebihara K; Aizawa-Abe M; Ebihara C; Zhao M; Yamamoto Y; Mashimo T; Hosoda K; Serikawa T; Nakao K
    Diabetes; 2016 Oct; 65(10):2954-65. PubMed ID: 27381370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization.
    Jennewein C; von Knethen A; Schmid T; Brüne B
    J Biol Chem; 2010 Apr; 285(16):11846-53. PubMed ID: 20164187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
    Bozina T; Simić I; Lovrić J; Pećin I; Jelaković B; Sertić J; Reiner Z
    Coll Antropol; 2013 Sep; 37(3):801-8. PubMed ID: 24308220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
    Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
    Lüdtke A; Buettner J; Wu W; Muchir A; Schroeter A; Zinn-Justin S; Spuler S; Schmidt HH; Worman HJ
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2248-55. PubMed ID: 17356052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-specific peroxisome proliferator activated receptor gamma expression and metabolic effects of telmisartan.
    Zídek V; Mlejnek P; Simáková M; Silhavy J; Landa V; Kazdová L; Pravenec M; Kurtz TW
    Am J Hypertens; 2013 Jun; 26(6):829-35. PubMed ID: 23426788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome.
    Cardona F; Morcillo S; Gonzalo-Marín M; Garrido-Sanchez L; Macias-Gonzalez M; Tinahones FJ
    Clin Chem; 2006 Oct; 52(10):1920-5. PubMed ID: 16916989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-301a is involved in adipocyte dysfunction during obesity-related inflammation via suppression of PPARγ.
    Li H; Xue M; Xu J; Qin X
    Pharmazie; 2016 Feb; 71(2):84-8. PubMed ID: 27004372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
    Wyles CC; Paradise CR; Houdek MT; Slager SL; Terzic A; Behfar A; van Wijnen AJ; Sierra RJ
    Clin Orthop Relat Res; 2019 Aug; 477(8):1800-1812. PubMed ID: 31135556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.